25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

7081 (Pharmaniaga) Stock Analysis
Buy, Hold or Sell?

Let's analyze Pharmaniaga together

I guess you are interested in Pharmaniaga Bhd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Pharmaniagaโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Pharmaniagaโ€™s Price Targets

I'm going to help you getting a better view of Pharmaniaga Bhd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pharmaniaga Bhd

I send you an email if I find something interesting about Pharmaniaga Bhd.

1. Quick Overview

1.1. Quick analysis of Pharmaniaga (30 sec.)










1.2. What can you expect buying and holding a share of Pharmaniaga? (30 sec.)

How much money do you get?

How much money do you get?
RM0.00
When do you have the money?
1 year
How often do you get paid?
51.7%

What is your share worth?

Current worth
RM-0.02
Expected worth in 1 year
RM0.00
How sure are you?
72.4%

+ What do you gain per year?

Total Gains per Share
RM0.02
Return On Investment
6.9%

For what price can you sell your share?

Current Price per Share
RM0.29
Expected price per share
RM0.22 - RM0.27944565217391
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharmaniaga (5 min.)




Live pricePrice per Share (EOD)
RM0.29
Intrinsic Value Per Share
RM1.07 - RM1.29
Total Value Per Share
RM1.05 - RM1.27

2.2. Growth of Pharmaniaga (5 min.)




Is Pharmaniaga growing?

Current yearPrevious yearGrowGrow %
How rich?-$28.2m-$60m$28.2m88.6%

How much money is Pharmaniaga making?

Current yearPrevious yearGrowGrow %
Making money$8.1m-$3.3m$11.5m141.1%
Net Profit Margin3.3%-1.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharmaniaga (5 min.)




2.4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharmaniaga?

Welcome investor! Pharmaniaga's management wants to use your money to grow the business. In return you get a share of Pharmaniaga.

First you should know what it really means to hold a share of Pharmaniaga. And how you can make/lose money.

Speculation

The Price per Share of Pharmaniaga is RM0.285. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmaniaga.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmaniaga, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is RM-0.02. Based on the TTM, the Book Value Change Per Share is RM0.00 per quarter. Based on the YOY, the Book Value Change Per Share is RM-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is RM0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmaniaga.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 RM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per Share
Usd Eps0.000.1%0.000.4%0.00-0.2%0.00-0.6%0.00-0.2%0.00-0.2%
Usd Book Value Change Per Share0.000.0%0.000.4%0.00-0.4%0.00-0.6%0.00-0.3%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share0.000.0%0.000.4%0.00-0.4%0.00-0.5%0.00-0.2%0.00-0.2%
Usd Price Per Share0.06-0.07-0.09-0.09-0.30-0.47-
Price to Earnings Ratio97.28-91.14-51.82-101.33-356.66-630.60-
Price-to-Total Gains Ratio1,918.93-638.42--499.44-86.20-1,079.92-979.51-
Price to Book Ratio-13.03--14.74--10.10--11.58-12.16-22.80-
Price-to-Total Gains Ratio1,918.93-638.42--499.44-86.20-1,079.92-979.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.068058
Number of shares14693
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (14693 shares)17.27-6.68
Gains per Year (14693 shares)69.08-26.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10695924-51-37
2013812848-102-64
3020719773-153-91
4027626697-204-118
50345335121-255-145
60414404145-306-172
70484473170-357-199
80553542194-408-226
90622611218-459-253
100691680242-510-280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%16.04.00.080.0%24.05.00.082.8%25.05.00.083.3%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%12.08.00.060.0%16.013.00.055.2%17.013.00.056.7%
Dividend per Share0.00.04.00.0%5.00.07.041.7%11.00.09.055.0%15.00.014.051.7%15.00.015.050.0%
Total Gains per Share4.00.00.0100.0%8.04.00.066.7%15.05.00.075.0%21.08.00.072.4%22.08.00.073.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pharmaniaga Bhd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.005-98%-0.005+4286%-0.007+5546%-0.004+3066%-0.004+2987%
Book Value Per Share---0.018-0.020+13%-0.038+113%-0.021+19%0.010-272%0.030-161%
Current Ratio--0.6470.634+2%0.584+11%0.657-2%0.777-17%0.794-19%
Debt To Asset Ratio--1.0551.063-1%1.126-6%1.074-2%0.973+8%0.893+18%
Debt To Equity Ratio----0%-0%0.429-100%2.123-100%2.142-100%
Dividend Per Share----0%0.000-100%0.000-100%0.002-100%0.002-100%
Enterprise Value---579475976.320-122434421.520-79%353890794.240-264%301373729.067-292%6308550548.637-109%11144607604.593-105%
Eps--0.0010.005-88%-0.002+456%-0.007+1260%-0.003+549%-0.002+464%
Ev To Ebitda Ratio---5.871-1.235-79%-2.236-62%3.082-290%2.993-296%11.047-153%
Ev To Sales Ratio---0.156-0.030-81%0.104-250%0.089-276%2.019-108%4.130-104%
Free Cash Flow Per Share---0.0010.004-127%-0.005+415%-0.001-40%-0.002+128%-0.003+171%
Free Cash Flow To Equity Per Share--0.0020.003-45%0.001+18%0.002+16%0.009-80%0.009-80%
Gross Profit Margin--1.0006.385-84%1.981-50%3.130-68%2.278-56%1.881-47%
Intrinsic Value_10Y_max--1.287----------
Intrinsic Value_10Y_min--1.067----------
Intrinsic Value_1Y_max--0.017----------
Intrinsic Value_1Y_min--0.016----------
Intrinsic Value_3Y_max--0.136----------
Intrinsic Value_3Y_min--0.128----------
Intrinsic Value_5Y_max--0.358----------
Intrinsic Value_5Y_min--0.325----------
Market Cap1868753518.080+18%1540902023.6801991697828.480-23%2532652794.240-39%2445225729.067-37%8284840048.637-81%12883546259.765-88%
Net Profit Margin--0.0040.033-87%-0.018+513%-0.058+1456%-0.024+672%-0.019+552%
Operating Margin---0.038-100%0.001-100%0.014-100%0.009-100%0.004-100%
Operating Ratio--0.9740.971+0%0.998-2%1.047-7%1.360-28%1.464-33%
Pb Ratio-15.798-21%-13.027-14.736+13%-10.105-22%-11.583-11%12.160-207%22.801-157%
Pe Ratio117.977+18%97.27991.145+7%51.818+88%101.331-4%356.662-73%630.599-85%
Price Per Share0.285+18%0.2350.304-23%0.386-39%0.373-37%1.264-81%1.965-88%
Price To Free Cash Flow Ratio-71.975-21%-59.348-27.938-53%-37.624-37%-17.756-70%-24.291-59%-58.137-2%
Price To Total Gains Ratio2327.215+18%1918.932638.423+201%-499.444+126%86.197+2126%1079.922+78%979.511+96%
Quick Ratio--0.3440.331+4%0.282+22%0.296+16%0.311+10%0.315+9%
Return On Assets--0.0020.016-88%-0.007+506%-0.027+1540%-0.012+734%-0.010+617%
Return On Equity----0%-0%-0.0030%0.022-100%0.002-100%
Total Gains Per Share--0.0000.005-98%-0.005+4285%-0.006+5287%-0.002+1655%-0.002+1572%
Usd Book Value---28246935.600-31849293.300+13%-60082856.100+113%-33562524.100+19%16408724.100-272%46681529.793-161%
Usd Book Value Change Per Share--0.0000.001-98%-0.001+4286%-0.002+5546%-0.001+3066%-0.001+2987%
Usd Book Value Per Share---0.004-0.005+13%-0.009+113%-0.005+19%0.003-272%0.007-161%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%0.000-100%
Usd Enterprise Value---138378863.145-29237339.859-79%84509121.665-264%71968046.501-292%1506481871.015-109%2661332295.977-105%
Usd Eps--0.0000.001-88%-0.001+456%-0.002+1260%-0.001+549%-0.001+464%
Usd Free Cash Flow---1550050.8005734602.900-127%-7988277.900+415%-936633.300-40%-3537404.100+128%-3186308.400+106%
Usd Free Cash Flow Per Share--0.0000.001-127%-0.001+415%0.000-40%-0.001+128%-0.001+171%
Usd Free Cash Flow To Equity Per Share--0.0000.001-45%0.000+18%0.000+16%0.002-80%0.002-80%
Usd Market Cap446258340.118+18%367967403.255475617441.441-23%604797487.265-39%583919904.101-37%1978419803.615-81%3076590846.832-88%
Usd Price Per Share0.068+18%0.0560.073-23%0.092-39%0.089-37%0.302-81%0.469-88%
Usd Profit--945648.0008174004.600-88%-3362602.500+456%-11406182.500+1306%-4506848.520+577%-3625634.524+483%
Usd Revenue--221335123.200235127076.900-6%207666927.600+7%216986256.800+2%223296029.400-1%203809410.041+9%
Usd Total Gains Per Share--0.0000.001-98%-0.001+4285%-0.002+5287%0.000+1655%0.000+1572%
 EOD+6 -2MRQTTM+9 -27YOY+26 -123Y+24 -155Y+20 -2010Y+21 -19

3.3 Fundamental Score

Let's check the fundamental score of Pharmaniaga Bhd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15117.977
Price to Book Ratio (EOD)Between0-1-15.798
Net Profit Margin (MRQ)Greater than00.004
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.344
Current Ratio (MRQ)Greater than10.647
Debt to Asset Ratio (MRQ)Less than11.055
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.002
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Pharmaniaga Bhd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.275
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Pharmaniaga Bhd

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.

Fundamental data was last updated by Penke on 2025-09-12 22:58:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Pharmaniaga earns for each RM1 of revenue.

  • Above 10% is considered healthy but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A Net Profit Margin of 0.4%ย means thatย RM0.00 for each RM1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharmaniaga Bhd:

  • The MRQ is 0.4%. The company is not making a profit/loss.
  • The TTM is 3.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM3.3%-2.9%
TTM3.3%YOY-1.8%+5.1%
TTM3.3%5Y-2.4%+5.8%
5Y-2.4%10Y-1.9%-0.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%1.4%-1.0%
TTM3.3%1.2%+2.1%
YOY-1.8%1.5%-3.3%
3Y-5.8%1.8%-7.6%
5Y-2.4%2.1%-4.5%
10Y-1.9%2.2%-4.1%
4.3.1.2. Return on Assets

Shows howย efficientย Pharmaniaga is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • 0.2% Return on Assets means thatย Pharmaniaga generatedย RM0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharmaniaga Bhd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.2%TTM1.6%-1.4%
TTM1.6%YOY-0.7%+2.3%
TTM1.6%5Y-1.2%+2.8%
5Y-1.2%10Y-1.0%-0.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%0.7%-0.5%
TTM1.6%0.7%+0.9%
YOY-0.7%0.8%-1.5%
3Y-2.7%0.6%-3.3%
5Y-1.2%0.7%-1.9%
10Y-1.0%0.9%-1.9%
4.3.1.3. Return on Equity

Shows how efficient Pharmaniaga is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • 0.0% Return on Equity means Pharmaniaga generated RM0.00ย for eachย RM1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharmaniaga Bhd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y0.2%+2.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.1%-2.1%
TTM-2.1%-2.1%
YOY-2.2%-2.2%
3Y-0.3%1.8%-2.1%
5Y2.2%2.0%+0.2%
10Y0.2%2.2%-2.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pharmaniaga Bhd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Pharmaniaga is operatingย .

  • Measures how much profit Pharmaniaga makes for each RM1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • An Operating Margin of 0.0%ย means the company generated RM0.00 ย for each RM1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharmaniaga Bhd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.8%-3.8%
TTM3.8%YOY0.1%+3.6%
TTM3.8%5Y0.9%+2.9%
5Y0.9%10Y0.4%+0.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-3.0%
TTM3.8%2.5%+1.3%
YOY0.1%2.5%-2.4%
3Y1.4%2.4%-1.0%
5Y0.9%3.0%-2.1%
10Y0.4%2.6%-2.2%
4.3.2.2. Operating Ratio

Measures how efficient Pharmaniaga is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Medical Distribution industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are RM0.97 for each RM1 in net sales.

Let's take a look of the Operating Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.974. The company is less efficient in keeping operating costs low.
  • The TTM is 0.971. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.974TTM0.971+0.003
TTM0.971YOY0.998-0.027
TTM0.9715Y1.360-0.389
5Y1.36010Y1.464-0.103
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9741.521-0.547
TTM0.9711.194-0.223
YOY0.9980.993+0.005
3Y1.0471.041+0.006
5Y1.3601.018+0.342
10Y1.4641.006+0.458
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pharmaniaga Bhd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharmaniaga is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Medical Distribution industry mean).
  • A Current Ratio of 0.65ย means the company has RM0.65 in assets for each RM1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.647. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.634. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.647TTM0.634+0.013
TTM0.634YOY0.584+0.050
TTM0.6345Y0.777-0.143
5Y0.77710Y0.794-0.017
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6471.316-0.669
TTM0.6341.370-0.736
YOY0.5841.395-0.811
3Y0.6571.381-0.724
5Y0.7771.356-0.579
10Y0.7941.345-0.551
4.4.3.2. Quick Ratio

Measures if Pharmaniaga is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A Quick Ratio of 0.34ย means the company can pay off RM0.34 for each RM1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.331. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.344TTM0.331+0.012
TTM0.331YOY0.282+0.049
TTM0.3315Y0.311+0.020
5Y0.31110Y0.315-0.003
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3440.663-0.319
TTM0.3310.718-0.387
YOY0.2820.823-0.541
3Y0.2960.820-0.524
5Y0.3110.859-0.548
10Y0.3150.970-0.655
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pharmaniaga Bhd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Pharmaniagaย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Pharmaniaga to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 1.05ย means that Pharmaniaga assets areย financed with 105.5% credit (debt) and the remaining percentage (100% - 105.5%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 1.055. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.063. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.055TTM1.063-0.008
TTM1.063YOY1.126-0.062
TTM1.0635Y0.973+0.091
5Y0.97310Y0.893+0.079
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0550.618+0.437
TTM1.0630.620+0.443
YOY1.1260.623+0.503
3Y1.0740.620+0.454
5Y0.9730.602+0.371
10Y0.8930.600+0.293
4.5.4.2. Debt to Equity Ratio

Measures ifย Pharmaniaga is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A Debt to Equity ratio of 0.0% means that company has RM0.00 debt for each RM1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.123-2.123
5Y2.12310Y2.142-0.019
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.675-1.675
TTM-1.670-1.670
YOY-1.682-1.682
3Y0.4291.695-1.266
5Y2.1231.748+0.375
10Y2.1421.764+0.378
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every RM1 in earnings Pharmaniaga generates.

  • Above 15 is considered overpriced butย always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A PE ratio of 97.28 means the investor is paying RM97.28ย for every RM1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharmaniaga Bhd:

  • The EOD is 117.977. Based on the earnings, the company is expensive. -2
  • The MRQ is 97.279. Based on the earnings, the company is expensive. -2
  • The TTM is 91.145. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD117.977MRQ97.279+20.698
MRQ97.279TTM91.145+6.134
TTM91.145YOY51.818+39.327
TTM91.1455Y356.662-265.517
5Y356.66210Y630.599-273.938
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD117.97712.222+105.755
MRQ97.2799.133+88.146
TTM91.1459.015+82.130
YOY51.81812.720+39.098
3Y101.33114.091+87.240
5Y356.66213.743+342.919
10Y630.59914.407+616.192
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharmaniaga Bhd:

  • The EOD is -71.975. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -59.348. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -27.938. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-71.975MRQ-59.348-12.627
MRQ-59.348TTM-27.938-31.410
TTM-27.938YOY-37.624+9.686
TTM-27.9385Y-24.291-3.646
5Y-24.29110Y-58.137+33.846
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-71.9755.787-77.762
MRQ-59.3486.134-65.482
TTM-27.9386.345-34.283
YOY-37.6244.332-41.956
3Y-17.7568.870-26.626
5Y-24.2915.208-29.499
10Y-58.1376.145-64.282
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Pharmaniaga is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Medical Distribution industry mean).
  • A PB ratio of -13.03 means the investor is paying RM-13.03ย for each RM1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharmaniaga Bhd:

  • The EOD is -15.798. Based on the equity, the company is expensive. -2
  • The MRQ is -13.027. Based on the equity, the company is expensive. -2
  • The TTM is -14.736. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.798MRQ-13.027-2.772
MRQ-13.027TTM-14.736+1.709
TTM-14.736YOY-10.105-4.631
TTM-14.7365Y12.160-26.896
5Y12.16010Y22.801-10.641
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-15.7980.933-16.731
MRQ-13.0270.835-13.862
TTM-14.7360.856-15.592
YOY-10.1051.140-11.245
3Y-11.5831.086-12.669
5Y12.1601.183+10.977
10Y22.8011.595+21.206
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in MYR. All numbers in thousands.

Summary
Total Assets2,151,004
Total Liabilities2,269,291
Total Stockholder Equity-142,573
 As reported
Total Liabilities 2,269,291
Total Stockholder Equity+ -142,573
Total Assets = 2,151,004

Assets

Total Assets2,151,004
Total Current Assets1,369,188
Long-term Assets781,816
Total Current Assets
Cash And Cash Equivalents 148,913
Net Receivables 578,170
Inventory 607,472
Other Current Assets 34,633
Total Current Assets  (as reported)1,369,188
Total Current Assets  (calculated)1,369,188
+/-0
Long-term Assets
Property Plant Equipment 608,558
Goodwill 77,150
Intangible Assets 72,133
Long-term Assets  (as reported)781,816
Long-term Assets  (calculated)757,841
+/- 23,975

Liabilities & Shareholders' Equity

Total Current Liabilities2,115,469
Long-term Liabilities153,822
Total Stockholder Equity-142,573
Total Current Liabilities
Short-term Debt 1,062,375
Short Long Term Debt 1,057,116
Accounts payable 959,613
Other Current Liabilities 79,190
Total Current Liabilities  (as reported)2,115,469
Total Current Liabilities  (calculated)3,158,294
+/- 1,042,825
Long-term Liabilities
Long term Debt 100,017
Capital Lease Obligations 6,823
Long-term Liabilities  (as reported)153,822
Long-term Liabilities  (calculated)106,840
+/- 46,982
Total Stockholder Equity
Common Stock200,046
Retained Earnings -437,873
Other Stockholders Equity 95,254
Total Stockholder Equity (as reported)-142,573
Total Stockholder Equity (calculated)-142,573
+/-0
Other
Capital Stock200,046
Cash and Short Term Investments 148,913
Common Stock Shares Outstanding 2,424,299
Liabilities and Stockholders Equity 2,151,004
Net Debt 1,015,043
Net Invested Capital 1,014,560
Net Working Capital -746,281
Property Plant and Equipment Gross 608,558
Short Long Term Debt Total 1,163,956



6.2. Balance Sheets Structured

Currency in MYR. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312016-03-312015-12-312015-09-302015-06-30
> Total Assets 
1,427,000
1,474,000
1,496,000
1,574,000
1,905,136
1,917,879
1,944,461
1,592,302
1,699,415
1,813,208
1,765,665
1,580,157
1,905,658
2,547,892
2,382,710
2,257,863
2,467,583
2,440,944
2,551,246
1,847,291
2,121,509
2,062,093
1,961,577
1,914,854
2,064,143
2,079,595
2,146,266
1,992,306
2,139,198
2,151,004
2,151,0042,139,1981,992,3062,146,2662,079,5952,064,1431,914,8541,961,5772,062,0932,121,5091,847,2912,551,2462,440,9442,467,5832,257,8632,382,7102,547,8921,905,6581,580,1571,765,6651,813,2081,699,4151,592,3021,944,4611,917,8791,905,1361,574,0001,496,0001,474,0001,427,000
   > Total Current Assets 
782,000
792,000
769,000
831,000
1,048,790
1,062,547
1,084,253
933,711
1,054,222
1,161,047
1,125,903
926,244
1,247,948
1,882,528
1,720,692
1,621,194
1,828,190
1,776,254
1,866,070
1,194,806
1,356,900
1,295,878
1,161,971
1,107,466
1,261,113
1,272,946
1,340,901
1,204,291
1,357,753
1,369,188
1,369,1881,357,7531,204,2911,340,9011,272,9461,261,1131,107,4661,161,9711,295,8781,356,9001,194,8061,866,0701,776,2541,828,1901,621,1941,720,6921,882,5281,247,948926,2441,125,9031,161,0471,054,222933,7111,084,2531,062,5471,048,790831,000769,000792,000782,000
       Cash And Cash Equivalents 
16,000
18,000
23,000
28,000
0
0
39,423
29,587
34,230
32,718
36,540
40,696
62,781
65,501
53,776
52,359
136,542
39,887
28,069
52,849
56,621
27,774
30,726
127,441
86,602
66,765
66,428
152,203
138,190
148,913
148,913138,190152,20366,42866,76586,602127,44130,72627,77456,62152,84928,06939,887136,54252,35953,77665,50162,78140,69636,54032,71834,23029,58739,4230028,00023,00018,00016,000
       Short-term Investments 
0
0
3,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,726
4,110
0
0
0
2,865
0
6,496
12,778
8,567
0
0
008,56712,7786,49602,8650004,1104,7260000000000000003,00000
       Net Receivables 
249,000
281,000
182,000
285,000
426,312
414,428
465,548
204,100
506,766
485,112
457,346
237,411
544,839
822,720
522,672
297,722
456,266
455,263
509,203
261,751
552,362
583,131
546,593
285,220
592,070
578,927
637,043
407,513
609,734
578,170
578,170609,734407,513637,043578,927592,070285,220546,593583,131552,362261,751509,203455,263456,266297,722522,672822,720544,839237,411457,346485,112506,766204,100465,548414,428426,312285,000182,000281,000249,000
       Inventory 
517,000
492,000
540,000
518,000
558,891
589,539
562,436
617,909
511,961
640,745
629,370
586,713
630,411
984,078
1,135,896
1,264,369
1,225,068
1,267,833
1,304,113
767,263
732,513
672,991
566,315
580,643
550,944
595,950
620,345
612,793
583,842
607,472
607,472583,842612,793620,345595,950550,944580,643566,315672,991732,513767,2631,304,1131,267,8331,225,0681,264,3691,135,896984,078630,411586,713629,370640,745511,961617,909562,436589,539558,891518,000540,000492,000517,000
   > Long-term Assets 
0
0
0
0
0
0
860,208
658,591
645,193
652,161
639,762
653,913
657,710
665,364
662,018
636,669
639,393
664,690
685,176
652,485
764,609
766,215
799,606
807,388
803,030
806,649
805,365
788,015
781,445
781,816
781,816781,445788,015805,365806,649803,030807,388799,606766,215764,609652,485685,176664,690639,393636,669662,018665,364657,710653,913639,762652,161645,193658,591860,208000000
       Property Plant Equipment 
0
0
0
0
421,134
419,563
417,694
410,110
403,265
402,199
395,063
398,471
399,704
407,077
399,810
395,590
397,289
421,131
434,495
443,034
576,239
576,349
577,487
605,748
604,041
603,228
603,647
609,355
604,196
608,558
608,558604,196609,355603,647603,228604,041605,748577,487576,349576,239443,034434,495421,131397,289395,590399,810407,077399,704398,471395,063402,199403,265410,110417,694419,563421,1340000
       Goodwill 
127,000
130,000
133,000
130,000
131,292
132,410
132,783
132,783
127,004
133,715
129,800
131,105
130,919
131,105
133,601
129,475
129,661
130,221
131,712
77,341
77,447
77,577
77,517
77,468
77,468
77,387
75,161
77,305
75,128
77,150
77,15075,12877,30575,16177,38777,46877,46877,51777,57777,44777,341131,712130,221129,661129,475133,601131,105130,919131,105129,800133,715127,004132,783132,783132,410131,292130,000133,000130,000127,000
       Intangible Assets 
0
0
0
0
265,824
266,057
269,596
67,559
66,808
72,193
71,598
73,932
76,083
77,737
72,924
78,538
80,258
81,257
85,292
72,393
84,340
86,571
76,197
72,090
71,791
16,037
74,913
74,012
75,203
72,133
72,13375,20374,01274,91316,03771,79172,09076,19786,57184,34072,39385,29281,25780,25878,53872,92477,73776,08373,93271,59872,19366,80867,559269,596266,057265,8240000
       Other Assets 
0
0
0
0
38,096
37,302
40,135
48,139
48,116
44,054
43,301
50,405
51,004
49,445
55,683
33,066
32,185
32,081
33,677
88,459
26,583
90,930
0
0
0
0
51,644
27,343
26,918
0
026,91827,34351,644000090,93026,58388,45933,67732,08132,18533,06655,68349,44551,00450,40543,30144,05448,11648,13940,13537,30238,0960000
> Total Liabilities 
873,000
911,000
936,000
1,033,000
1,376,163
1,397,104
1,409,292
1,254,451
1,349,440
1,455,186
1,420,106
1,242,629
1,548,935
2,189,828
1,990,870
1,807,401
2,053,439
2,034,440
2,117,475
2,195,599
2,240,699
2,175,023
2,200,351
2,188,944
2,310,307
2,326,980
2,296,434
2,138,250
2,258,288
2,269,291
2,269,2912,258,2882,138,2502,296,4342,326,9802,310,3072,188,9442,200,3512,175,0232,240,6992,195,5992,117,4752,034,4402,053,4391,807,4011,990,8702,189,8281,548,9351,242,6291,420,1061,455,1861,349,4401,254,4511,409,2921,397,1041,376,1631,033,000936,000911,000873,000
   > Total Current Liabilities 
839,000
874,000
894,000
989,000
1,272,960
1,292,472
1,323,445
1,200,581
1,300,295
1,402,510
1,370,804
1,193,819
1,497,322
2,023,244
1,636,639
1,467,763
1,698,220
1,672,854
1,766,156
2,067,710
1,953,425
1,892,458
1,923,585
2,002,447
2,137,724
2,154,959
2,138,140
1,953,073
2,104,400
2,115,469
2,115,4692,104,4001,953,0732,138,1402,154,9592,137,7242,002,4471,923,5851,892,4581,953,4252,067,7101,766,1561,672,8541,698,2201,467,7631,636,6392,023,2441,497,3221,193,8191,370,8041,402,5101,300,2951,200,5811,323,4451,292,4721,272,960989,000894,000874,000839,000
       Short-term Debt 
430,000
505,000
400,000
598,000
0
0
0
564,616
640,025
676,631
728,847
668,837
534,515
811,560
484,942
543,979
525,048
610,745
782,132
1,071,427
1,035,736
919,851
922,408
1,051,670
1,089,070
1,081,091
1,123,010
1,059,147
1,052,725
1,062,375
1,062,3751,052,7251,059,1471,123,0101,081,0911,089,0701,051,670922,408919,8511,035,7361,071,427782,132610,745525,048543,979484,942811,560534,515668,837728,847676,631640,025564,616000598,000400,000505,000430,000
       Short Long Term Debt 
430,000
505,000
400,000
598,000
0
0
709,346
564,616
640,025
676,631
728,847
668,837
789,515
1,007,560
516,242
569,679
653,648
781,353
776,502
967,753
1,029,857
914,059
916,628
1,047,050
1,085,616
1,078,887
1,119,455
1,054,669
1,048,554
1,057,116
1,057,1161,048,5541,054,6691,119,4551,078,8871,085,6161,047,050916,628914,0591,029,857967,753776,502781,353653,648569,679516,2421,007,560789,515668,837728,847676,631640,025564,616709,34600598,000400,000505,000430,000
       Accounts payable 
396,000
359,000
437,000
384,000
0
0
594,632
548,994
650,174
716,215
625,045
441,562
697,472
986,746
1,072,010
677,633
945,339
847,735
947,114
414,879
881,095
940,784
970,092
390,953
980,183
1,001,194
924,954
800,971
955,660
959,613
959,613955,660800,971924,9541,001,194980,183390,953970,092940,784881,095414,879947,114847,735945,339677,6331,072,010986,746697,472441,562625,045716,215650,174548,994594,63200384,000437,000359,000396,000
       Other Current Liabilities 
14,000
10,000
44,000
8,000
0
0
341
341
341
341
0
0
0
0
0
0
0
0
36,910
581,404
33,308
27,690
26,156
550,029
57,591
57,894
58,610
82,496
85,467
79,190
79,19085,46782,49658,61057,89457,591550,02926,15627,69033,308581,40436,91000000000341341341341008,00044,00010,00014,000
   > Long-term Liabilities 
0
0
0
0
0
0
85,847
34,795
31,801
33,315
31,460
31,373
32,267
146,880
333,304
319,659
334,050
340,134
351,319
127,889
287,274
282,565
276,766
186,497
172,583
172,021
158,294
185,177
153,888
153,822
153,822153,888185,177158,294172,021172,583186,497276,766282,565287,274127,889351,319340,134334,050319,659333,304146,88032,26731,37331,46033,31531,80134,79585,847000000
       Long term Debt Total 
0
0
0
0
8,299
8,629
5,281
2,441
3,355
0
2,380
927
695
116,933
294,420
285,611
299,839
303,529
313,857
194,665
225,662
222,933
0
0
0
0
115,702
132,749
101,337
0
0101,337132,749115,7020000222,933225,662194,665313,857303,529299,839285,611294,420116,9336959272,38003,3552,4415,2818,6298,2990000
       Capital Lease Obligations 
0
0
0
0
0
0
14,844
4,263
5,458
4,856
4,446
2,913
2,395
2,854
2,417
2,192
1,943
7,288
11,537
10,673
10,139
8,604
7,408
5,711
4,239
2,850
6,090
7,661
6,190
6,823
6,8236,1907,6616,0902,8504,2395,7117,4088,60410,13910,67311,5377,2881,9432,1922,4172,8542,3952,9134,4464,8565,4584,26314,844000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,462
31,224
0
59,632
0
0
0
0
0
0
0
0
0000000059,632031,22437,462000000000000000000
> Total Stockholder Equity
0
0
0
0
528,973
520,775
515,953
337,851
349,975
358,022
345,559
337,528
356,723
358,064
391,840
450,462
414,144
406,504
411,161
-369,694
-142,768
-137,972
-263,671
-299,066
-272,109
-272,998
-174,918
-171,275
-144,078
-142,573
-142,573-144,078-171,275-174,918-272,998-272,109-299,066-263,671-137,972-142,768-369,694411,161406,504414,144450,462391,840358,064356,723337,528345,559358,022349,975337,851515,953520,775528,9730000
   Common Stock
141,000
141,000
141,000
141,000
149,401
151,879
151,879
151,879
151,879
153,339
153,339
153,339
153,339
154,051
154,051
154,051
154,051
154,051
154,051
154,189
154,189
154,189
200,046
200,046
200,046
200,046
200,046
200,046
200,046
200,046
200,046200,046200,046200,046200,046200,046200,046200,046154,189154,189154,189154,051154,051154,051154,051154,051154,051153,339153,339153,339153,339151,879151,879151,879151,879149,401141,000141,000141,000141,000
   Retained Earnings Total Equity000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,134
1,343
104,581
105,726
104,461
104,307
105,618
101,867
0
0
97,709
0
097,70900101,867105,618104,307104,461105,726104,5811,3439,134000000000000000000
   Capital Surplus 
0
0
0
0
8,657
7,543
6,693
7,191
7,689
3,333
3,440
1,996
2,104
0
403
1,670
2,672
3,674
4,008
3,624
3,624
3,624
0
0
0
0
3,624
3,624
3,624
0
03,6243,6243,62400003,6243,6243,6244,0083,6742,6721,67040302,1041,9963,4403,3337,6897,1916,6937,5438,6570000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
414
2,541
3,264
3,289
-7,484
6,020
-1,450
452
-1,277
-954
2,233
1,016
1,460
2,576
9,134
0
235
105,726
104,461
104,307
105,618
0
98,915
100,091
97,709
95,254
95,25497,709100,09198,9150105,618104,307104,461105,72623509,1342,5761,4601,0162,233-954-1,277452-1,4506,020-7,4843,2893,2642,5414140000



6.3. Balance Sheets

Currency in MYR. All numbers in thousands.




6.4. Cash Flows

Currency in MYR. All numbers in thousands.




6.5. Income Statements

Currency in MYR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in MYR. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,759,479
Cost of Revenue-3,218,985
Gross Profit540,494540,494
 
Operating Income (+$)
Gross Profit540,494
Operating Expense-262,486
Operating Income278,008278,008
 
Operating Expense (+$)
Research Development8,631
Selling General Administrative279,568
Selling And Marketing Expenses153,026
Operating Expense262,486441,225
 
Net Interest Income (+$)
Interest Income2,252
Interest Expense-71,969
Other Finance Cost-0
Net Interest Income-69,717
 
Pretax Income (+$)
Operating Income278,008
Net Interest Income-69,717
Other Non-Operating Income Expenses-
Income Before Tax (EBT)194,180361,836
EBIT - interestExpense = 188,957
192,208
203,791
Interest Expense71,969
Earnings Before Interest and Taxes (EBIT)260,926266,149
Earnings Before Interest and Taxes (EBITDA)288,494
 
After tax Income (+$)
Income Before Tax194,180
Tax Provision-60,386
Net Income From Continuing Ops133,794133,794
Net Income131,822
Net Income Applicable To Common Shares131,822
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,498,553
Total Other Income/Expenses Net-83,82869,717
 

Technical Analysis of Pharmaniaga
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmaniaga. The general trend of Pharmaniaga is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmaniaga's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Pharmaniaga Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharmaniaga Bhd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.255635 < 0.26459176470588 < 0.27944565217391.

The bearish price targets are: 0.243745 > 0.235 > 0.22.

Know someone who trades $7081? Share this with them.๐Ÿ‘‡

Pharmaniaga Bhd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharmaniaga Bhd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharmaniaga Bhd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Moving Average Convergence/Divergence (MACD) ChartPharmaniaga Bhd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharmaniaga Bhd. The current adx is .

Pharmaniaga Bhd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Relative Strength Index (RSI) ChartPharmaniaga Bhd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Stochastic Oscillator ChartPharmaniaga Bhd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Commodity Channel Index (CCI) ChartPharmaniaga Bhd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Chande Momentum Oscillator (CMO) ChartPharmaniaga Bhd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Williams %R ChartPharmaniaga Bhd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Average True Range (ATR) ChartPharmaniaga Bhd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily On-Balance Volume (OBV) ChartPharmaniaga Bhd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Money Flow Index (MFI) ChartPharmaniaga Bhd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharmaniaga Bhd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Pharmaniaga Bhd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharmaniaga Bhd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.275
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharmaniaga with someone you think should read this too:
  • Are you bullish or bearish on Pharmaniaga? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmaniaga? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharmaniaga Bhd

I send you an email if I find something interesting about Pharmaniaga Bhd.


Comments

How you think about this?

Leave a comment

Stay informed about Pharmaniaga Bhd.

Receive notifications about Pharmaniaga Bhd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.